OncoStem

CanAssist Breast

Book your test

Scientific Publications

Sengupta, A., et al (2020). Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX. Cancer Medicine. doi: 10.1002/cam4.3495
Patil, P., et al. (2020). CanAssist breast: An affordable breast cancer prognostic test validated on Asian patients. doi: 10.1200/JCO.2020.38.15_suppl.541
Krishnamurthy A (2020). Breast cancer prognostic tools: A promising Indian option. Int J Mol Immuno Oncol 2020;5(2):47-8. doi: 10.25259/IJMIO_15_2020
Bhattacharyya, G. S., et al. (2020). Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective. JCO Global Oncology, 6, 789-798. doi: 10.1200/GO.20.00033
Sankaran, S., et al. (2019). CanAssist Breast impacting clinical treatment decisions in early-stage HR+ breast cancer patients: Indian scenario. Indian Journal of Surgical Oncology, 1-9. doi: 0.1007/s13193-019-01014-4
Bakre, M. (2019). 242P Clinical validation of CanAssist breast in a Spanish cohort. Annals of Oncology, 30(Supplement_5), mdz240-066. doi: 10.1093/annonc/mdz240.066
Gopalakrishnan, V., et al. (2019). Impact of CanAssist-Breast in clinical treatment decisions in early stage HR+ breast cancer patients: Asian Scenario. Journal of Global Oncology 5, no. suppl (October 07, 2019) 109-109. doi: 10.1200/JGO.2019.5.suppl
Bakre, M. M., et al. (2019). Clinical validation of an immunohistochemistry-based CanAssist Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.Cancer medicine 1-10. doi: 10.1002/cam4.2049
Attuluri., A. K., et al (2019). Analytical Validation of the immunohistochemistry-based CanAssist Breast Prognostic Test for Prediction of Risk of Recurrence in Hormone Receptor- Positive Breast Cancer. BMC Cancer 19:249. doi: 10.1186/s12885-019-5443-5
Ramkumar, C., et al. (2018). Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer. Biomarker insights, 13, 1177271918789100. doi: 10.1177/1177271918789100
Prakash, C., et al. (2018). Risk stratification in early-stage estrogen receptor+ /HER2-breast cancer patients: Comparative analysis of cost-effective methods
Bakre, M. (2018). 4P CanAssist-Breast-an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: A cost-effective and accurate solution for Asia. Annals of Oncology, 29(suppl_9), mdy426-003. doi: 10.1093/annonc/mdy426.003
Somashekhar, S., et al. (2017). 1675P Risk of recurrence prediction and optimum treatment planning for early-stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia
Ramkumar, C., et al. (2017). Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study

Want to know about your recurrence risk?

to personalize your cancer treatment and reduce the risk & side effects of chemotheraphy